Claris Lifesciences gets USFDA approval for finished dosage and API plants

09 Jul 2014 Evaluate

Claris Lifesciences has received a report from US Food and Drug Administration (USFDA) for the inspection it conducted classifying the finished dosage plant and API plant as acceptable.

Claris Lifesciences is one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.

Peers
Company Name CMP
Redington 271.15
Adani Enterprises 2231.85
Amrapali Industries 14.81
Rashi Peripheral 357.00
PDS 366.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×